Gastrointestinal Cancer Archives | VJOncology

The GI Cancer Channel on VJOncology is supported by Seagen. This supporter has no influence over the production of the content.

View overview page

The use of ctDNA in patient cancer care

Arvind Dasari • 1 Feb 2022

CIRCULATE-US: investigating the use of ctDNA to detect MRD

Arvind Dasari • 1 Feb 2022

Investigating fruquintinib in patients with refractory metastatic CRC

Arvind Dasari • 1 Feb 2022

Treating patients with gastric cancer with immunotherapy: who will benefit?

Sun Young Rha • 25 Jan 2022

Immune checkpoint inhibitors and combination strategies for patients with gastric cancer

Sun Young Rha • 25 Jan 2022

HER-RAM: investigating trastuzumab, ramucirumab and paclitaxel for the second-line treatment of GC

Sun Young Rha • 25 Jan 2022

A Phase II trial: dostarlimab alone for the treatment of dMMR locally advanced rectal cancer

Melissa Lumish • 24 Jan 2022

Highlights and key clinical trial updates from ASCO GI 2022

Melissa Lumish • 24 Jan 2022

The remaining challenges surrounding the use of immunotherapy to treat patients with rectal cancer

Melissa Lumish • 24 Jan 2022

The challenges in implementing CAR-T cell therapy for the treatment of solid tumors

Richard D. Kim • 27 Jan 2022

TOPAZ-1: the addition of durvalumab to chemotherpay for the treatment of BTC in the 1st-line setting

Richard D. Kim • 27 Jan 2022

Rationale behind combining a VEGF/Ang2-blocking nanobody and immunotherpay in advanced CRC

Susanna Varkey • 28 Jan 2022

HIMALAYA: tremelimumab + durvalumab in unresectable HCC

Richard D. Kim • 27 Jan 2022

Investigating ezabenlimab in combination with a VEGF/Ang2-blocking nanobody for advanced CRC

Susanna Varkey • 28 Jan 2022

Immunotherapy plus TKIs for the treatment of CRC

Richard D. Kim • 27 Jan 2022

Unanswered questions on the use of immunotherapy in CRC

Susanna Varkey • 28 Jan 2022

1
2
3
Next